Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.32
AMS's Cash to Debt is ranked higher than
74% of the 306 Companies
in the Global Medical Care industry.

( Industry Median: 0.19 vs. AMS: 0.32 )
AMS' s 10-Year Cash to Debt Range
Min: 0   Max: 1.04
Current: 0.32

0
1.04
Equity to Asset 0.33
AMS's Equity to Asset is ranked higher than
63% of the 307 Companies
in the Global Medical Care industry.

( Industry Median: 0.41 vs. AMS: 0.33 )
AMS' s 10-Year Equity to Asset Range
Min: -0.58   Max: 0.43
Current: 0.33

-0.58
0.43
Interest Coverage 0.62
AMS's Interest Coverage is ranked lower than
51% of the 198 Companies
in the Global Medical Care industry.

( Industry Median: 5.04 vs. AMS: 0.62 )
AMS' s 10-Year Interest Coverage Range
Min: 0.32   Max: 2.54
Current: 0.62

0.32
2.54
F-Score: 3
Z-Score: 0.55
M-Score: -3.09
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating margin (%) -1.10
AMS's Operating margin (%) is ranked higher than
57% of the 309 Companies
in the Global Medical Care industry.

( Industry Median: 8.52 vs. AMS: -1.10 )
AMS' s 10-Year Operating margin (%) Range
Min: -20.53   Max: 45.83
Current: -1.1

-20.53
45.83
Net-margin (%) -7.11
AMS's Net-margin (%) is ranked higher than
55% of the 309 Companies
in the Global Medical Care industry.

( Industry Median: 4.94 vs. AMS: -7.11 )
AMS' s 10-Year Net-margin (%) Range
Min: -13.25   Max: 57.1
Current: -7.11

-13.25
57.1
ROE (%) -5.45
AMS's ROE (%) is ranked higher than
58% of the 289 Companies
in the Global Medical Care industry.

( Industry Median: 10.03 vs. AMS: -5.45 )
AMS' s 10-Year ROE (%) Range
Min: -1.58   Max: 1872.38
Current: -5.45

-1.58
1872.38
ROA (%) -1.59
AMS's ROA (%) is ranked higher than
59% of the 310 Companies
in the Global Medical Care industry.

( Industry Median: 3.52 vs. AMS: -1.59 )
AMS' s 10-Year ROA (%) Range
Min: -1.24   Max: 70.39
Current: -1.59

-1.24
70.39
ROC (Joel Greenblatt) (%) -0.33
AMS's ROC (Joel Greenblatt) (%) is ranked higher than
59% of the 309 Companies
in the Global Medical Care industry.

( Industry Median: 18.24 vs. AMS: -0.33 )
AMS' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -63.93   Max: 24.73
Current: -0.33

-63.93
24.73
Revenue Growth (%) 1.80
AMS's Revenue Growth (%) is ranked higher than
65% of the 242 Companies
in the Global Medical Care industry.

( Industry Median: 7.10 vs. AMS: 1.80 )
AMS' s 10-Year Revenue Growth (%) Range
Min: -44.3   Max: 27.8
Current: 1.8

-44.3
27.8
EBITDA Growth (%) -3.30
AMS's EBITDA Growth (%) is ranked higher than
62% of the 195 Companies
in the Global Medical Care industry.

( Industry Median: 6.80 vs. AMS: -3.30 )
AMS' s 10-Year EBITDA Growth (%) Range
Min: -34.3   Max: 124.1
Current: -3.3

-34.3
124.1
» AMS's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with AMS

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)



No Guru Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 0.60
AMS's P/B is ranked higher than
97% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 2.93 vs. AMS: 0.60 )
AMS' s 10-Year P/B Range
Min: 0.26   Max: 1.99
Current: 0.6

0.26
1.99
P/S 0.70
AMS's P/S is ranked higher than
84% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 1.57 vs. AMS: 0.70 )
AMS' s 10-Year P/S Range
Min: 0.24   Max: 2.18
Current: 0.7

0.24
2.18
PFCF 1.50
AMS's PFCF is ranked higher than
100% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 53.33 vs. AMS: 1.50 )
AMS' s 10-Year PFCF Range
Min: 0.86   Max: 56
Current: 1.5

0.86
56
EV-to-EBIT -205.75
AMS's EV-to-EBIT is ranked higher than
60% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 24.30 vs. AMS: -205.75 )
AMS' s 10-Year EV-to-EBIT Range
Min: -213.4   Max: 89
Current: -205.75

-213.4
89
Current Ratio 0.88
AMS's Current Ratio is ranked higher than
60% of the 310 Companies
in the Global Medical Care industry.

( Industry Median: 1.32 vs. AMS: 0.88 )
AMS' s 10-Year Current Ratio Range
Min: 0.18   Max: 4.13
Current: 0.88

0.18
4.13
Quick Ratio 0.88
AMS's Quick Ratio is ranked higher than
62% of the 310 Companies
in the Global Medical Care industry.

( Industry Median: 1.19 vs. AMS: 0.88 )
AMS' s 10-Year Quick Ratio Range
Min: 0.18   Max: 4.13
Current: 0.88

0.18
4.13

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 0.61
AMS's Price/Tangible Book is ranked higher than
98% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 15.23 vs. AMS: 0.61 )
AMS' s 10-Year Price/Tangible Book Range
Min: 0.27   Max: 2.45
Current: 0.61

0.27
2.45
Price/DCF (Projected) 0.21
AMS's Price/DCF (Projected) is ranked higher than
100% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 4.02 vs. AMS: 0.21 )
AMS' s 10-Year Price/DCF (Projected) Range
Min: 0.15   Max: 1.02
Current: 0.21

0.15
1.02
Price/Median PS Value 0.92
AMS's Price/Median PS Value is ranked higher than
87% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 1.19 vs. AMS: 0.92 )
AMS' s 10-Year Price/Median PS Value Range
Min: 0.04   Max: 4.67
Current: 0.92

0.04
4.67
Earnings Yield (Greenblatt) -0.50
AMS's Earnings Yield (Greenblatt) is ranked higher than
58% of the 306 Companies
in the Global Medical Care industry.

( Industry Median: 4.60 vs. AMS: -0.50 )
AMS' s 10-Year Earnings Yield (Greenblatt) Range
Min: 1.1   Max: 9.9
Current: -0.5

1.1
9.9
Forward Rate of Return (Yacktman) 32.67
AMS's Forward Rate of Return (Yacktman) is ranked higher than
94% of the 212 Companies
in the Global Medical Care industry.

( Industry Median: 12.92 vs. AMS: 32.67 )
AMS' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 1.6   Max: 56.7
Current: 32.67

1.6
56.7

Business Description

Industry: Health Care Providers » Medical Care
Compare:CHE, FMS, DVA, FSNUY, BDUUF » details
Traded in other countries:AZS.Germany,
American Shared Hospital Services was incorporated in the State of California in 1983 and its predecessor, Ernest A. Bates, M.D., Ltd. (d/b/a American Shared Hospital Services), a California limited partnership, was formed in June 1980. It provides Gamma Knife stereotactic radiosurgery equipment and radiation therapy and related equipment to seventeen (17) medical centers in sixteen (16) states in the United States and two medical centers in Turkey, as of March 1, 2013. The Gamma Knife stereotactic radiosurgery is a non-invasive procedure and an alternative to conventional brain surgery or can be an adjunct to conventional brain surgery, radiation therapy, or chemotherapy. Compared to conventional surgery, Gamma Knife radiosurgery usually involves shorter patient hospitalization, lower risk of complications and can be provided at a lower cost. Typically, Gamma Knife patients resume their pre-surgical activities one or two days after treatment. The Gamma Knife treats patients with 201 single doses of gamma rays that are focused with great precision on small and medium sized, well circumscribed and critically located structures in the brain. During 2006 Elekta introduced a new Gamma Knife model, the Perfexion unit, which treats patients with 192 single doses of gamma rays and will also provide the ability to perform procedures on areas of the upper cervical spine. The Gamma Knife delivers a concentrated dose of gamma rays from Cobalt-60 sources housed in the Gamma Knife. The Cobalt-60 sources converge at the target area and deliver a dose that is high enough to destroy the diseased tissue without damaging surrounding healthy tissue. The Gamma Knife treats selected malignant and benign brain tumors, arteriovenous malformations, and functional disorders including trigeminal neuralgia (facial pain). Research is being conducted to determine whether the Gamma Knife can be effective in the treatment of epilepsy and other functional disorders. Conventional neurosurgery, radiation therapy and other radiosurgery devices are the primary competitors of Gamma Knife radiosurgery. The Medicare program is administered by the Centers for Medicare and Medicaid Services of the U.S. Department of Health and Human Services.
» More Articles for AMS

Headlines

Articles On GuruFocus.com

More From Other Websites
Johnson Matthey sells gold and silver refining unit to Japan's Asahi Dec 15 2014
AMERICAN SHARED HOSPITAL SERVICES Files SEC form 8-K, Entry into a Material Definitive Agreement,... Dec 11 2014
Sibanye, Northam among suitors of Anglo's Union mine Dec 03 2014
Sibanye, Northam among bidders for Anglo's Union mine-sources Dec 03 2014
Amplats expects full-year earnings to drop at least 20 pct Dec 01 2014
Anglo American Platinum sees FY earnings falling at least 20 pct Dec 01 2014
AMERICAN SHARED HOSPITAL SERVICES Financials Nov 22 2014
Top six platinum producers launch investment promotion body Nov 18 2014
10-Q for American Shared Hospital Services Nov 17 2014
AMERICAN SHARED HOSPITAL SERVICES Files SEC form 10-Q, Quarterly Report Nov 14 2014
AMERICAN SHARED HOSPITAL SERVICES Files SEC form 8-K, Results of Operations and Financial Condition,... Nov 13 2014
American Shared Hospital Services Reports Third Quarter Results Nov 13 2014
Q3 2014 American Shared Hospital Services Earnings Release - Time Not Supplied Nov 13 2014
Platinum industry to promote investment demand for metal Nov 10 2014
American Shared Hospital Services Announces Third Quarter 2014 Results Earnings Conference Call Nov 07 2014
American Shared Hospital Services Announces Third Quarter 2014 Results Earnings Conference Call Nov 07 2014
AMSC Prices Equity Offering Nov 07 2014
BUZZ-Platinum producers: reaping benefits of weaker rand Nov 07 2014
AMSC Reports Second Quarter Fiscal 2014 Financial Results and Provides Business Outlook Nov 06 2014
American Shared Hospital Services Announces Delivery of MEVION S250 Proton Accelerator to UF Health... Nov 04 2014

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK